CURE Epilepsy Update: January 2021

Greetings CURE Epilepsy community,
Beth Lewin Dean

Happy New Year! The whole team at CURE Epilepsy would like to thank you for all the support you have shown us through a challenging and unpredictable year. Your tenacity, courage, and dedication inspire us daily. Your commitment has helped make it possible to continue researching for a cure during these difficult circumstances.  
 
Because of your support, we were able to fund a record number of research grants ([link removed]) last year, including two Catalyst Awards, our newest grant mechanism. Additionally, to support researchers impacted by COVID-19, we established the CURE Epilepsy Research Continuity Fund ([link removed]) to provide grants of up to $15,000 each to epilepsy researchers to cover unexpected costs due to the pandemic.  
 
Epilepsy has not stopped during this pandemic, and with your help we will continue to drive science forward. Together we remain unfaltering in our commitment to deliver on our mission of promoting and funding patient-focused research to find a cure for epilepsy.
In this CURE Epilepsy update, please also find information on:
* Upcoming Webinar: Cenobamate (Xcopri®): A New Treatment for Partial-Onset (Focal) Seizures ([link removed])
* Download the CURE Epilepsy Research News Mobile App ([link removed])
* Apply for a CURE Epilepsy Scholarship ([link removed])
* What’s New from the Seizing Life® Podcast ([link removed])

Wishing you health and happiness in 2021!

Beth Lewin Dean, CEO


** Webinar: Cenobamate (Xcopri®)  A New Treatment for Partial-Onset (Focal) Seizures
------------------------------------------------------------
Register ([link removed])

[link removed]

Cenobamate is the latest approved antiepileptic drug for partial-onset (focal) seizures. On Wednesday, January 27 at 1:00 pm CT, join us for a webinar ([link removed])  that will share what is known about how cenobamate reduces seizure activity, as well as the potential side effects that patients and caregivers should be aware of when considering this treatment option.

This webinar is supported with funding from SK Life Science.


** Get the CURE Epilepsy Research News Mobile App
------------------------------------------------------------
Learn More ([link removed])

[link removed]

The latest epilepsy discoveries are at your fingertips with the CURE Epilepsy Research News mobile app. The app provides you with summaries of current research from epileptologists, neurologists, and organizations dedicated to building a world without epilepsy. Download the CURE Epilepsy Research News App on either the Google Play ([link removed])  or Apple App Store ([link removed]) .


** Apply for a CURE Epilepsy Scholarship
------------------------------------------------------------
Learn More ([link removed])

[link removed]

Applications are now open for the Education Enrichment Fund ([link removed]) , a program that provides a one-time scholarship (up to $5,000) for those living with epilepsy, family members, or caregivers. These scholarships, generously funded by Greenwich Biosciences, support coursework in scholars’ chosen fields, so they can use their knowledge and skills to become agents of change in the epilepsy community. Apply now! ([link removed])


** New from Seizing Life^®, a CURE Epilepsy Podcast
------------------------------------------------------------
Watch or listen ([link removed])

[link removed]

Catch up on the latest episodes of our Seizing Life podcast where we share:
* An overview of how an epilepsy drug is developed, from foundational basic research supported by organizations like CURE Epilepsy to submission to the Food and Drug Administration. Listen or Watch ([link removed])
* A look into how clinical trials work, and what processes ensure the well-being of the volunteers and the collection of unbiased data by researchers. Listen or Watch ([link removed])

Visit our website ([link removed]) to learn more about other exciting events we have planned.
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]
[link removed]-
[link removed]
[link removed]

============================================================
Copyright © 2021 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA